190 related articles for article (PubMed ID: 12640108)
21. Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.
Asano E; Okano K; Oshima M; Kagawa S; Kushida Y; Munekage M; Hanazaki K; Watanabe J; Takada Y; Ikemoto T; Shimada M; Suzuki Y;
J Surg Oncol; 2016 Jul; 114(1):119-27. PubMed ID: 27132476
[TBL] [Abstract][Full Text] [Related]
22. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH
Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191
[TBL] [Abstract][Full Text] [Related]
24. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
[TBL] [Abstract][Full Text] [Related]
25. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
Maitra A; Molberg K; Albores-Saavedra J; Lindberg G
Am J Pathol; 2000 Oct; 157(4):1105-11. PubMed ID: 11021814
[TBL] [Abstract][Full Text] [Related]
26. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
27. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
28. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
29. DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases.
Agaram NP; Shia J; Tang LH; Klimstra DS
Am J Clin Pathol; 2010 May; 133(5):772-80. PubMed ID: 20395525
[TBL] [Abstract][Full Text] [Related]
30. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.
Overman MJ; Soifer HS; Schueneman AJ; Ensor J; Adsay V; Saka B; Neishaboori N; Wolff RA; Wang H; Schnabel CA; Varadhachary G
BMC Cancer; 2016 Aug; 16(1):668. PubMed ID: 27549176
[TBL] [Abstract][Full Text] [Related]
31. High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.
Nassar H; Albores-Saavedra J; Klimstra DS
Am J Surg Pathol; 2005 May; 29(5):588-94. PubMed ID: 15832081
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
33. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
[TBL] [Abstract][Full Text] [Related]
34. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
35. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
36. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
[TBL] [Abstract][Full Text] [Related]
37. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.
Sohn TA; Su GH; Ryu B; Yeo CJ; Kern SE
Ann Surg; 2001 May; 233(5):696-703. PubMed ID: 11323508
[TBL] [Abstract][Full Text] [Related]
38. ras-family gene mutations in neoplasia of the ampulla of Vater.
Scarpa A; Zamboni G; Achille A; Capelli P; Bogina G; Iacono C; Serio G; Accolla RS
Int J Cancer; 1994 Oct; 59(1):39-42. PubMed ID: 7927901
[TBL] [Abstract][Full Text] [Related]
39. K-ras mutation in adenomas and carcinomas of the ampulla of vater.
Howe JR; Klimstra DS; Cordon-Cardo C; Paty PB; Park PY; Brennan MF
Clin Cancer Res; 1997 Jan; 3(1):129-33. PubMed ID: 9815548
[TBL] [Abstract][Full Text] [Related]
40. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.
Ando T; Sugai T; Habano W; Jiao YF; Suzuki K
J Gastroenterol; 2005 Jul; 40(7):708-15. PubMed ID: 16082587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
